Discover the top 35 companies transforming the immunoassay market, including Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, and other industry leaders. Backed by a market projected to grow from $34.4B to $47.7B by 2030 at a CAGR of 6.1%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.
Download PDF Brochure:“Click Here”
Spotlights on the Industry’s Top Immunoassay Companies
Abbott
Abbott is a global healthcare leader that maintains a dominant position in the immunoassay market through its core laboratory diagnostics business. Its flagship Alinity and ARCHITECT systems are industry standards for high-throughput, automated immunoassay testing across clinical chemistry and infectious disease screening. The company differentiates itself through integrated laboratory solutions and a vast menu of assays for oncology, cardiology, and metabolic disorders, further strengthened by its rapid diagnostic portfolio such as the BinaxNOW and Panbio series for point-of-care applications.
F. Hoffmann-La Roche Ltd.
Roche is a premier player in the global immunoassay market, recognized for its cobas e series analyzers and proprietary Elecsys technology. The company offers a comprehensive menu of high-sensitivity assays used extensively for oncology, cardiac markers, infectious diseases, and reproductive health. Roche focuses on high-speed automation and standardized reagent systems to optimize laboratory workflows, maintaining its leadership through continuous R\&D into novel biomarkers and integrated digital diagnostics.
Siemens Healthineers AG
Siemens Healthineers is a leading provider of automated immunoassay systems, notably through its Atellica Solution and ADVIA Centaur platforms. The company specializes in high-throughput diagnostic solutions that integrate immunoassay and clinical chemistry testing to improve operational efficiency. By leveraging AI-driven automation and a broad testing menu that includes advanced specialty assays for brain health and chronic disease management, Siemens Healthineers remains a critical partner for large-scale hospital and reference laboratories.
Danaher
Danaher Corporation operates as a powerhouse in the immunoassay sector primarily through its subsidiary, Beckman Coulter Diagnostics. Its Access and DxI immunoassay platforms are renowned for high-performance automation and sensitivity in detecting biomarkers for cardiology, oncology, and endocrine disorders. Danaher utilizes its proprietary Danaher Business System (DBS) to drive continuous innovation and efficiency, while its Cepheid subsidiary leads in molecular diagnostics, creating a multifaceted diagnostic ecosystem.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific is a global leader in life sciences that provides a robust portfolio of immunoassay reagents, kits, and instruments through brands like Invitrogen and Phadia. The company is particularly strong in the specialty diagnostics segment, offering industry-leading solutions for allergy and autoimmune disease testing. Its comprehensive range of high-quality antibodies and protein quantitation kits supports both clinical diagnostics and biopharmaceutical research, making it a foundational supplier for the global laboratory market.
Revvity
Revvity, formerly part of PerkinElmer, is a specialized health science company that provides advanced immunoassay solutions focused on newborn screening, prenatal testing, and life sciences research. The company excels in high-sensitivity detection technologies and multiplexing capabilities, enabling researchers and clinicians to quantify multiple biomarkers simultaneously. Revvity’s strategic focus on “translational” science links laboratory research to clinical outcomes through specialized kits and automated liquid handling systems.
Becton, Dickinson and Company (BD)
BD is a global medical technology company that contributes to the immunoassay market through its expertise in flow cytometry and specimen collection. While primarily recognized for its BD Veritor system for rapid point-of-care testing, the company also provides essential reagents and sophisticated systems for cell analysis and immune monitoring. BD’s products are vital for diagnostic workflows, offering integrated solutions that ensure sample integrity and precise detection in clinical and research settings.
DiaSorin S.p.A.
DiaSorin is an Italian biotechnology multinational that specializes in the immunodiagnostics niche, offering a wide array of specialized tests on its LIAISON series of automated analyzers. The company is a global leader in specialty segments such as Vitamin D testing, bone metabolism, and various infectious diseases including latent tuberculosis. DiaSorin’s business model focuses on “niche” high-value assays that provide clinical differentiation and high margins within the broader diagnostics landscape.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories is a prominent provider of clinical diagnostic and life science research products, offering a diverse range of immunoassay technologies. The company is a leader in the quality control market and provides specialized platforms for diabetes monitoring (HbA1c) and blood virus screening. Bio-Rad’s expertise in multiplex immunoassays and digital PCR technology allows for precise analyte quantification, serving a global customer base of hospitals, blood banks, and research institutes.
QuidelOrtho Corporation
Formed by the merger of Quidel and Ortho Clinical Diagnostics, QuidelOrtho is a major force in the immunoassay market, bridging point-of-care testing with high-volume clinical laboratory solutions. The company’s Vitros systems utilize dry-slide technology for reliable clinical chemistry and immunoassay testing, while its Sofia and Triage brands lead in rapid cardiovascular and infectious disease diagnostics. QuidelOrtho focuses on decentralizing healthcare by providing accurate diagnostic insights at the first point of patient contact.
bioMérieux
bioMérieux is a world leader in the field of in vitro diagnostics, with a particular emphasis on infectious disease management. Its VIDAS system is one of the most widely installed automated immunoassay platforms globally, used for high-quality testing in small-to-medium-sized laboratories. The company focuses on clinical microbiology and provides essential assays for emergency markers (such as Procalcitonin for sepsis), helping clinicians make rapid and life-saving therapeutic decisions.
QIAGEN
QIAGEN is a leading global provider of Sample to Insight solutions, contributing significantly to the immunoassay market with its QuantiFERON technology. This specialized interferon-gamma release assay (IGRA) is the global gold standard for latent tuberculosis detection. QIAGEN’s immunoassay portfolio complements its dominant molecular diagnostics business, focusing on high-growth segments such as immune response monitoring and personalized medicine through companion diagnostics.
Sysmex Corporation
Sysmex is a Japanese diagnostic leader known for its global dominance in hematology, which it has leveraged to expand into the immunoassay market with its HISCL series. These analyzers utilize chemiluminescence enzyme immunoassay (CLEIA) technology to provide rapid, high-sensitivity testing for infectious diseases, cancer biomarkers, and cardiac markers. Sysmex focuses on total laboratory automation and digitalization, integrating immunoassay data into broader clinical information systems for enhanced diagnostic accuracy.
Agilent Technologies, Inc.
Agilent Technologies provides core bioanalytical and laboratory technologies, contributing to the immunoassay space through its Dako brand, a leader in immunohistochemistry (IHC) and companion diagnostics. The company specializes in identifying tissue-based biomarkers that guide personalized cancer therapies. Agilent’s analytical expertise extends to high-performance reagents and tools for protein analysis, supporting the development of next-generation biopharmaceuticals and precision medicine workflows.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Mindray is a leading global medical device manufacturer based in China that has rapidly expanded its presence in the immunoassay market with its CL-series chemiluminescence analyzers. The company offers cost-effective, high-throughput systems that are increasingly competitive in emerging and developed markets alike. Mindray’s portfolio covers a broad range of routine and specialty assays, emphasizing robust engineering, ease of use, and local support to challenge established Western diagnostic giants.
Merck KGaA
Merck KGaA, operating as MilliporeSigma in North America, is a key supplier to the immunoassay market through its extensive range of specialized reagents, antibodies, and multiplex assay platforms like SMC (Single Molecule Counting). The company provides ultra-sensitive detection technologies that allow for the measurement of biomarkers at previously undetectable levels. Merck KGaA supports the entire diagnostic value chain, from early-stage biomarker discovery in research to large-scale manufacturing of diagnostic components.
Meridian Bioscience
Meridian Bioscience is a fully integrated life science company that develops, manufactures, and distributes a broad range of innovative diagnostic test kits, primarily for gastrointestinal and respiratory infectious diseases. The company is well-regarded for its immunoassay-based tests for C. difficile, H. pylori, and foodborne pathogens. Additionally, Meridian is a major supplier of raw materials (such as antigens and antibodies) used by other diagnostic manufacturers, playing a critical role in the global supply chain.
Bio-Techne
Bio-Techne is a leading developer of high-quality proteins and reagents, notably through its R\&D Systems brand, which offers one of the world’s most extensive catalogs of ELISA kits. The company specializes in the “proteomics” space, providing advanced automated immunoassay platforms like Simple Plex (Ella), which delivers high-sensitivity, multianalyte results with minimal manual intervention. Bio-Techne’s products are essential for cell and gene therapy research and the discovery of novel clinical biomarkers.
Cellabs
Cellabs is an Australian biotechnology company that specializes in the development and manufacture of immunodiagnostic kits for tropical and infectious diseases. The company is a recognized expert in fluorescent antibody and ELISA technologies for diagnosing conditions such as malaria, Giardia, and Cryptosporidium. Cellabs serves a global market, providing reliable and affordable diagnostic tools that are essential for public health monitoring and clinical management in both developed and developing regions.
Abnova Corporation
Abnova is the world’s largest antibody manufacturer, maintaining a massive portfolio of monoclonal antibodies and ELISA kits for a wide variety of research and diagnostic targets. The company utilizes high-throughput genomic and proteomic platforms to rapidly develop new reagents, supporting the scientific community in functional genomics and drug discovery. Abnova’s extensive catalog makes it a primary source for specialized immunoassay components used across academic and industrial laboratories.
J. Mitra & Co. Pvt. Ltd.
J. Mitra & Co. is a leading Indian diagnostics company that has pioneered the indigenous development of immunoassay kits in the South Asian market. The company offers a comprehensive range of ELISA and rapid tests for infectious diseases such as HIV, Hepatitis, Dengue, and Malaria. Known for high-quality and affordable diagnostic solutions, J. Mitra plays a vital role in national health programs and decentralized clinical testing across India and emerging global markets.
Tosoh Corporation (Tosoh Biosciences)
Tosoh Bioscience is a Japanese multinational known for its AIA series of automated immunoassay analyzers, which utilize unique fluorescent enzyme immunoassay (FEIA) technology. The company’s systems are valued for their reliability, ease of use, and “all-in-one” reagent test cups that simplify laboratory workflows. Tosoh’s menu is particularly strong in endocrinology, thyroid function, and cardiac markers, serving a loyal customer base in hospital and physician office laboratories worldwide.
Cell Sciences
Cell Sciences is a specialized provider of high-quality proteins, antibodies, and immunoassay kits for life science research. The company offers an extensive range of ELISA and ELISpot kits designed for the detection of cytokines, chemokines, and growth factors. Cell Sciences caters to researchers in immunology, inflammation, and stem cell biology, providing validated reagents that ensure high specificity and reproducibility in complex biological studies.
Enzo Biochem Inc.
Enzo Biochem is a pioneer in molecular and cellular diagnostics, providing a diverse portfolio of immunoassay kits and reagents through its Enzo Life Sciences division. The company specializes in labeling and detection technologies, offering specialized assays for cell viability, oxidative stress, and signaling pathways. Enzo’s integrated model combines R\&D with manufacturing, delivering innovative tools that support drug discovery and the development of novel diagnostic applications.
Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, antigens, and immunoassay kits for various research and diagnostic fields. The company offers a vast selection of reagents for ELISA, lateral flow assays, and chemiluminescence, covering areas such as infectious diseases, food safety, and environmental monitoring. Creative Diagnostics is known for its ability to provide custom antibody production and assay development services, catering to the specific needs of the global biotechnology industry.
Boster Biological Technology
Boster Biological Technology is an antibody manufacturer specializing in high-affinity, high-specificity antibodies and ELISA kits. The company is widely recognized for its “Picokine” ELISA kits, which offer picogram-level sensitivity for detecting cytokines and other low-abundance proteins. Boster supports life science research with a focus on quality and affordability, providing validated reagents that have been cited in thousands of peer-reviewed publications across the globe.
Elabscience Bionovation Inc.
Elabscience is a high-tech biotechnology company specializing in immunodiagnostic reagents for the life science research community. The company offers a comprehensive range of ELISA kits, CLIA kits, and antibodies covering more than 20 species and numerous research areas such as cancer, immunology, and neuroscience. Elabscience emphasizes rigorous quality control and technical support, helping researchers achieve accurate and consistent results in their protein quantification experiments.
WAK-Chemie Medical GmbH
WAK-Chemie Medical is a German-based company that provides specialized diagnostic products and research reagents, with a focus on immunology and oncology. The company offers a range of high-quality immunoassay kits and accessories designed for clinical laboratories and research institutes. WAK-Chemie is known for its commitment to providing niche diagnostic solutions and maintaining high standards of regulatory compliance within the European healthcare market.
Sera Care
SeraCare, part of LGC Clinical Diagnostics, is a vital partner to diagnostic manufacturers and clinical laboratories, providing high-quality biological materials and quality control solutions. The company specializes in the development of reference materials, panels, and controls used to validate and monitor the performance of immunoassay and molecular tests. SeraCare’s products ensure the accuracy and reliability of diagnostic results for infectious diseases and oncology, supporting the advancement of precision medicine.
Epitope Diagnostics, Inc.
Epitope Diagnostics is a US-based company that develops, manufactures, and markets innovative immunoassay kits for clinical diagnostics and life science research. The company offers a unique portfolio of ELISA kits for specialized markers, such as those used in fecal testing for gastrointestinal health and metabolic monitoring. Epitope Diagnostics focuses on niche markets where high-quality, standardized assays can provide significant clinical value to healthcare providers.
Kamiya Biomedical Company
Kamiya Biomedical Company is a leading supplier of high-quality diagnostic reagents for clinical chemistry and life science research. The company specializes in providing immunoassay-based “K-ASSAY” reagents for various serum proteins and biomarkers on automated chemistry analyzers. Kamiya is well-regarded for its extensive menu of assays for cardiovascular risk, inflammatory markers, and veterinary diagnostics, serving laboratories with reliable and cost-effective testing solutions.
Gyros Protein Technologies AB
Gyros Protein Technologies is a pioneer in automated nanoliter-scale immunoassays, utilizing its proprietary Gyrolab platform. The company’s technology uses microfluidics on a compact disc (CD) to deliver high-quality data with minimal sample and reagent volumes. Gyros is a critical partner for the biopharmaceutical industry, where its systems are used for pharmacokinetics (PK), pharmacodynamics (PD), and impurities testing during drug development and manufacturing.
Trivitron Healthcare
Trivitron Healthcare is a major global medical technology company headquartered in India that provides a wide range of diagnostic solutions, including immunoassay systems. Through its acquisition of Labsystems Diagnostics, the company offers specialized kits for newborn screening and infectious diseases. Trivitron emphasizes affordable innovation, manufacturing high-quality diagnostic platforms that cater to the needs of healthcare providers in both emerging and developed economies.
InBios International, Inc.
InBios International is a leading developer of diagnostic tests for infectious diseases, with a strong focus on emerging and neglected tropical diseases. Based in the US, the company is recognized for its high-quality ELISA and rapid test kits for Zika, Dengue, Chikungunya, and West Nile virus. InBios plays a critical role in global public health, providing FDA-cleared and CE-marked diagnostic tools that enable early detection and outbreak monitoring.
Maccura Biotechnology Co., Ltd.
Maccura Biotechnology is one of China’s leading diagnostic companies, offering a comprehensive suite of immunoassay solutions, including high-throughput chemiluminescence analyzers and a wide range of reagents. The company focuses on “total laboratory solution” integration, combining immunoassay, clinical chemistry, and hematology into automated systems. Maccura’s commitment to international standards and R\&D excellence has allowed it to expand its footprint significantly beyond the domestic Chinese market.
Download PDF Brochure:“Click Here”
